LENZ Therapeutics Cash Flow Statement (2020-2026) | LENZ

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-17.53M-14.60M-18.94M-25.96M-26.78M-26.15M-26.75M-12.62M-14.71M-18.78M-24.14M-15.30M-10.25M-10.21M-12.65M-14.61M-14.91M-16.70M-35.90M-41.49M
Depreciation and Depletion (Quarter)
0.10M0.20M0.30M0.40M0.60M0.70M0.70M0.70M0.80M0.80M0.10M
Share-based Compensation (Quarter)
2.02M2.37M2.45M3.34M3.36M3.21M3.62M0.14M2.85M2.16M0.52M0.95M1.60M2.19M1.63M2.56M2.85M3.47M3.68M4.32M
Gains from Sales and Divestitures (Quarter)
0.24M0.29M0.35M0.40M0.45M0.50M0.55M0.60M0.65M0.70M0.75M
Gains from Investment Securities (Quarter)
0.01M0.30M0.04M0.02M0.14M1.69M0.01M-0.27M1.05M0.33M-0.33M-0.00M
Asset Writedowns and Impairment (Quarter)
7.21M13.35M0.08M
Cash from Restructuring (Quarter)
4.82M-4.77M
Non-cash Items (Quarter)
113.00M40.39M18.50M0.79M1.48M0.77M0.79M1.21M3.60M4.23M0.85M
Cash from Operations (Quarter)
-13.78M-15.41M-15.59M-21.24M-22.09M-22.22M-22.43M-12.80M-13.52M-13.09M-20.97M-23.94M-15.79M-10.58M-9.08M-16.05M-11.51M-8.59M-33.02M-33.58M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.04M-0.04M0.56M1.12M0.02M0.53M0.51M0.28M0.96M1.36M1.42M1.13M0.89M0.78M0.61M0.32M
Depreciation & Amortization (CF) (Quarter)
0.12M0.20M0.33M0.44M0.58M0.65M0.68M0.00M0.00M0.00M0.00M0.01M0.02M0.01M0.03M0.04M0.02M0.12M0.11M0.11M
Change in Working Capital
Change in Receivables (Quarter)
0.01M
Change in Inventory (Quarter)
3.33M0.89M
Change in Account Payables (Quarter)
3.37M-2.34M0.71M0.58M0.30M0.39M-1.08M-0.57M-1.63M1.97M1.09M-1.27M-2.69M-1.64M1.32M-0.77M-0.86M1.69M-0.16M6.76M
Change in Accured Expenses (Quarter)
0.44M0.94M1.03M-1.67M1.16M1.17M0.45M-0.15M2.98M3.34M1.62M-7.23M-2.25M0.72M1.30M-1.20M2.69M4.46M5.03M-2.11M
Investing Activities
Capital Expenditures (Quarter)
0.76M3.64M0.98M3.27M1.39M0.92M1.02M0.01M0.02M0.13M-0.10M0.17M0.11M0.24M0.44M0.04M0.02M
Sales of Property, Plant and Equipment (Quarter)
0.89M0.68M
Change in Acquisitions & Divestments (Quarter)
90.00M80.25M1.50M21.00M18.00M13.00M22.00M34.90M52.09M58.12M52.41M43.34M49.23M
Cash from Investing Activities (Quarter)
-0.76M-3.64M-0.98M-170.67M-88.22M3.50M13.52M-0.01M-26.88M-17.91M15.17M18.00M-98.39M-62.23M-11.86M18.89M-0.41M-4.33M-89.81M33.16M
Financing Activities
Other financing activities (Quarter)
1.91M
Change in Capital Stock
Shares Issued (Quarter)
219.19M-219.43M0.01M0.24M0.20M-0.20M0.20M-0.20M53.39M-49.54M0.06M0.14M0.04M26.10M0.60M0.04M0.01M
Preferred Shares Issued (Quarter)
14.82M66.00M16.98M
Misc.
Cash from Financing Activities (Quarter)
219.50M31.89M0.31M0.41M-0.06M0.24M83.18M-0.57M-1.91M171.27M-2.14M29.82M0.05M0.04M26.49M0.60M122.61M0.01M
Change in Cash (Quarter)
204.95M12.84M-16.26M-191.91M-109.90M-18.78M-8.66M70.38M-40.40M-31.57M-7.71M165.33M-116.32M-42.99M-20.89M2.88M14.57M-12.32M-0.22M-0.41M
Free Cash Flow (Quarter)
-14.55M-19.05M-16.57M-24.51M-23.48M-23.13M-23.45M-12.80M-13.55M-13.09M-20.97M-23.94M-15.93M-10.48M-9.25M-16.16M-11.75M-9.03M-33.06M-33.60M
Net Cash Flow (Quarter)
204.95M12.84M-16.26M-191.91M-109.90M-18.78M-8.66M70.38M-40.40M-31.57M-7.71M165.33M-116.32M-42.99M-20.89M2.88M14.57M-12.32M-0.22M-0.41M